CN Patent

CN107095875B — 一种昔奈酸沙美特罗丙酸氟替卡松复方粉吸入剂组合物

Assigned to Tianjin Jinyao Group Co Ltd · Expires 2022-03-18 · 4y expired

What this patent protects

本发明提供了一种昔奈酸沙美特罗丙酸氟替卡松复方粉吸入剂组合物，由丙酸氟替卡松、昔奈酸沙美特罗和三种不同粒径范围的乳糖按一定比例组成，该全新的丙酸氟替卡松和昔奈酸沙美特罗复方粉吸入剂组合物与市售的舒利迭 相比，肺部沉积率更高，经过加速稳定性试验考察表现出良好的稳定性。

USPTO Abstract

本发明提供了一种昔奈酸沙美特罗丙酸氟替卡松复方粉吸入剂组合物，由丙酸氟替卡松、昔奈酸沙美特罗和三种不同粒径范围的乳糖按一定比例组成，该全新的丙酸氟替卡松和昔奈酸沙美特罗复方粉吸入剂组合物与市售的舒利迭 相比，肺部沉积率更高，经过加速稳定性试验考察表现出良好的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN107095875B
Jurisdiction
CN
Classification
—
Expires
2022-03-18
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Jinyao Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.